Patrick David Reischling

US Patent:

20190025162, Jan 24, 2019

Filed:

Sep 20, 2018

Appl. No.:

16/137371

Inventors:

- Des Moines IA, US
Brian Leach - Broomfield CO, US
Ryan Dregalla - Broomfield CO, US
Patrick Reischling - Broomfield CO, US

International Classification:

G01N 1/14
B01D 21/26
A61M 1/36
A61B 5/153
A61B 5/15
B01L 3/00

Abstract:

Apparatus, systems and methods for processing a blood sample. One embodiment includes an isolation container having at least one sidewall defining an interior volume. The interior volume includes a medial reservoir in fluid communication with proximal and distal reservoirs. The diameter of the medial reservoir is less than the diameter of the proximal and distal reservoirs. Therefore, the isolation container has an interior volume which is roughly hour-glass shaped with the medial reservoir being a substantially narrowed portion or channel between two wider portions. The isolation container is configured such that the buffy coat layer of fractionated blood will be located within, or may be manipulated to be with the medial reservoir.

US Patent:

20180305655, Oct 25, 2018

Filed:

Apr 20, 2018

Appl. No.:

15/958940

Inventors:

- Des Moines IA, US
Ryan Dregalla - Broomfield CO, US
Nicolette Lyons - Broomfield CO, US
Patrick Reischling - Broomfield CO, US

International Classification:

C12M 1/00
C12N 5/077
B01L 3/00
A61M 1/02
C12M 1/26

Abstract:

The embodiments disclosed herein generally relate to systems, devices and methods for the fractionation, isolation, extraction and processing of the adipose supernatant layer of a bone marrow aspirate. In particular, the various embodiments relate to systems devices and methods of obtaining, utilizing and processing the adipose supernatant layer of a bone marrow aspirate as a source of mesenchymal stem cells.

US Patent:

20160317760, Nov 3, 2016

Filed:

Jan 20, 2015

Appl. No.:

15/107859

Inventors:

- Broomfield CO, US
Patrick REISCHLING - Broomfield CO, US
Timothy SNYDER - Broomfield CO, US

International Classification:

A61M 5/46
A61M 5/32

Abstract:

Embodiments include systems, methods and devices for the percutaneous delivery of therapeutic agents to tendons, ligaments and muscle. Certain embodiments include a device comprising a needle-catheter based delivery system with adjustable characteristics to allow a clinician to control the angle and depth of needle and/or catheter deployment to a desired location. System embodiments may include a controller unit where a clinician can adjust the axial position depth and location of needles and/or catheters.

US Patent:

20160298076, Oct 13, 2016

Filed:

Aug 6, 2014

Appl. No.:

14/778530

Inventors:

- Broomfield CO, US
Ryan Dregalla - Broomfield CO, US
Nicolette Lyons - Broomfield CO, US
Patrick Reischling - Broomfield CO, US

International Classification:

C12M 1/00
C12M 1/26
C12N 5/077
A61M 1/02

Abstract:

The embodiments disclosed herein generally relate to systems, devices and methods for the fractionation, isolation, extraction and processing of the adipose supernatant layer of a bone marrow aspirate. In particular, the various embodiments relate to systems devices and methods of obtaining, utilizing and processing the adipose supernatant layer of a bone marrow aspirate as a source of mesenchymal stem cells.

US Patent:

20160051261, Feb 25, 2016

Filed:

Apr 29, 2014

Appl. No.:

14/783788

Inventors:

- Broomfield CO, US
Patrick REISCHLING - Broomfield CO, US

International Classification:

A61B 17/11

Abstract:

A device for the approximation of tissue including a hollow tube housing an inner core. The inner core may be moved within the hollow tube between first and second positions. The inner core comprises a distal tip. When the inner core is placed into the first position, the distal tip extends away from or outside of the hollow tube such that the distal tip may become securely attached to a selected tissue at a desired location. Once secured to tissue, the distal tip is configured to approximate the torn tissue in a selected direction. Associated systems and methods are also disclosed.

US Patent:

20160002598, Jan 7, 2016

Filed:

Jan 28, 2014

Appl. No.:

14/761828

Inventors:

Chirstopher CENTENO - Broomfield CO, US
Brian J. LEACH - Broomfield CO, US
Ryan DREGALLA - Broomfield CO, US
Patrick REISCHLING - Broomfield CO, US
Nicolette LYONS - Broomfield CO, US
- Broomfield CO, US

Assignee:

Regenerative Science, LLC - Broomfield CO

International Classification:

C12N 5/078
C12M 3/04
C12M 1/00
C12M 1/42
A61K 35/19
C12N 13/00

Abstract:

Device, system and method embodiments are disclosed herein which provide for the production of a modified autologous platelet solution at the patient bedside for contemporaneous reinjection to the patient. In certain embodiments all of the steps including, but not limited to blood draw, platelet lysis, solution preparation and reinjection to a patient may be accomplished in a single office or clinic visit without relocating the patient. Accordingly, the apparatus, devices and systems disclosed herein generally include a substantially stand-alone machine, device or system which is configured to accept a platelet containing solution, induce lysis of one or more platelet bodies within the platelet containing solution and provide the resulting modified platelet solution in a manner suitable for injection into the patient.

US Patent:

20160003712, Jan 7, 2016

Filed:

Feb 18, 2014

Appl. No.:

14/767679

Inventors:

- Broomfield CO, US
Brian Leach - Broomfield CO, US
Ryan Dregalla - Broomfield CO, US
Patrick Reischling - Broomfield CO, US

International Classification:

G01N 1/14
A61M 1/36
B01D 21/26

Abstract:

Apparatus, systems and methods for processing a blood sample. One embodiment comprises an isolation container having at least one sidewall defining an interior volume. The interior volume includes a medial reservoir in fluid communication with proximal and distal reservoirs. The diameter of the medial reservoir is less than the diameter of the proximal and distal reservoirs. Therefore, the isolation container has an interior volume which is roughly hour-glass shaped with the medial reservoir being a substantially narrowed portion or channel between two wider portions. The isolation container is configured such that the buffy coat layer of fractionated blood will be located within and may be accessed from the reduced cross sectional medial reservoir after a centrifuge or other processing step.